266 related articles for article (PubMed ID: 23124885)
1. Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance.
Zhao F; Lam EW
Front Med; 2012 Dec; 6(4):376-80. PubMed ID: 23124885
[TBL] [Abstract][Full Text] [Related]
2. Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance.
Gomes AR; Zhao F; Lam EW
Chin J Cancer; 2013 Jul; 32(7):365-70. PubMed ID: 23706767
[TBL] [Abstract][Full Text] [Related]
3. Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance.
Nestal de Moraes G; Bella L; Zona S; Burton MJ; Lam EW
Curr Drug Targets; 2016; 17(2):164-77. PubMed ID: 25418858
[TBL] [Abstract][Full Text] [Related]
4. FOXO and FOXM1 in cancer: the FOXO-FOXM1 axis shapes the outcome of cancer chemotherapy.
Wilson MS; Brosens JJ; Schwenen HD; Lam EW
Curr Drug Targets; 2011 Aug; 12(9):1256-66. PubMed ID: 21443467
[TBL] [Abstract][Full Text] [Related]
5. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.
McGovern UB; Francis RE; Peck B; Guest SK; Wang J; Myatt SS; Krol J; Kwok JM; Polychronis A; Coombes RC; Lam EW
Mol Cancer Ther; 2009 Mar; 8(3):582-91. PubMed ID: 19276163
[TBL] [Abstract][Full Text] [Related]
6. The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance.
Yao S; Fan LY; Lam EW
Semin Cancer Biol; 2018 Jun; 50():77-89. PubMed ID: 29180117
[TBL] [Abstract][Full Text] [Related]
7. Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review).
Zhu H
Oncol Rep; 2014 Oct; 32(4):1327-34. PubMed ID: 25175498
[TBL] [Abstract][Full Text] [Related]
8. FOXM1: From cancer initiation to progression and treatment.
Koo CY; Muir KW; Lam EW
Biochim Biophys Acta; 2012 Jan; 1819(1):28-37. PubMed ID: 21978825
[TBL] [Abstract][Full Text] [Related]
9. FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.
Karadedou CT; Gomes AR; Chen J; Petkovic M; Ho KK; Zwolinska AK; Feltes A; Wong SY; Chan KY; Cheung YN; Tsang JW; Brosens JJ; Khoo US; Lam EW
Oncogene; 2012 Apr; 31(14):1845-58. PubMed ID: 21860419
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
11. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells.
Madureira PA; Varshochi R; Constantinidou D; Francis RE; Coombes RC; Yao KM; Lam EW
J Biol Chem; 2006 Sep; 281(35):25167-76. PubMed ID: 16809346
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.
Li X; Yao R; Yue L; Qiu W; Qi W; Liu S; Yao Y; Liang J
J Cell Mol Med; 2014 May; 18(5):811-23. PubMed ID: 24628949
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy: tailoring cancer treatment.
Yan M; Liu QQ
Chin J Cancer; 2013 Jul; 32(7):363-4. PubMed ID: 23823626
[TBL] [Abstract][Full Text] [Related]
15. FOXM1: A small fox that makes more tracks for cancer progression and metastasis.
Khan MA; Khan P; Ahmad A; Fatima M; Nasser MW
Semin Cancer Biol; 2023 Jul; 92():1-15. PubMed ID: 36958703
[TBL] [Abstract][Full Text] [Related]
16. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.
Khongkow P; Gomes AR; Gong C; Man EP; Tsang JW; Zhao F; Monteiro LJ; Coombes RC; Medema RH; Khoo US; Lam EW
Oncogene; 2016 Feb; 35(8):990-1002. PubMed ID: 25961928
[TBL] [Abstract][Full Text] [Related]
18. FoxM1 as a novel therapeutic target for cancer drug therapy.
Xu XS; Miao RC; Wan Y; Zhang LQ; Qu K; Liu C
Asian Pac J Cancer Prev; 2015; 16(1):23-9. PubMed ID: 25640357
[TBL] [Abstract][Full Text] [Related]
19. [Effects of AG1478 on the expression of FOXM1 gene via FOXO3a in non-small cell lung cancer cells].
Gong XD; Yuan HH; Wang JY; Guo YH; Shi J; Jiang B
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):572-8. PubMed ID: 24314213
[TBL] [Abstract][Full Text] [Related]
20. Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia.
Buchner M; Park E; Geng H; Klemm L; Flach J; Passegué E; Schjerven H; Melnick A; Paietta E; Kopanja D; Raychaudhuri P; Müschen M
Nat Commun; 2015 Mar; 6():6471. PubMed ID: 25753524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
